New Atlas2d
Next-gen weight-loss drugs will be here within 12 months
It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...
'Ozempic-like' weight loss drug Mounjaro creates buzz amid India launch: Price per month, availability, pros and cons
Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Here's ...
NBC 10 Philadelphia3d
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
"We had seen potential for CagriSema to demonstrate superior weight loss to Zepbound given the amylin component; however, the CagriSema delta from obese to obese diabetics patients looks very ...